U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT07507838) titled 'Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV913 Capsules' on March 27.
Brief Summary: This study is a single-center, randomized, double-blind, placebo-controlled, dose-escalation trial to assess the safety, tolerability, pharmacokinetics （PK） of multiple doses of VV913 in Chinese healthy adult participants.
Study Start Date: April 01
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: VV913 4mg group
6 participants will receive VV913 4mg orally; 2 participants will receive placebo orally.
DRUG: VV913 8mg group
6 participants will receive VV913 8mg orally; 2 parti...